Key signaling pathways in the muscle-invasive bladder carcinoma: Clinical markers for disease modeling and optimized treatment.
about
Implication of vascular endothelial growth factor A and C in revealing diagnostic lymphangiogenic markers in node-positive bladder cancer.Heterogeneous nuclear ribonucleoprotein K is associated with poor prognosis and regulates proliferation and apoptosis in bladder cancer.Simple and Efficient Stratification of Invasive Bladder Cancer Patients.ZKSCAN3 promotes bladder cancer cell proliferation, migration, and invasionMET/SMAD3/SNAIL circuit mediated by miR-323a-3p is involved in regulating epithelial-mesenchymal transition progression in bladder cancer.Distinct TP63 Isoform-Driven Transcriptional Signatures Predict Tumor Progression and Clinical Outcomes.The current status and clinical value of circulating tumor cells and circulating cell-free tumor DNA in bladder cancer.Benzidine Induces Epithelial-Mesenchymal Transition of Human Bladder Cancer Cells through Activation of ERK5 Pathway.Identification of Differentially Expressed Genes between Original Breast Cancer and Xenograft Using Machine Learning Algorithms.Epidermal growth factor receptor function in the human urothelium.
P2860
Q33591719-86B64462-5AF1-4A1B-A0F2-844C32766BE4Q33844635-2FA4F2EC-0FE8-4E1C-873B-4B63021E8345Q37363467-8D515728-3CAF-413F-AD1A-6EE8A03CA792Q37619797-F6E58F9E-1ADA-428F-9168-EF0AC15891F9Q38694277-FA2337AC-C52F-4164-8492-A231146C4642Q47406043-8E4CD3E6-4D8D-43FC-BF2B-5E45F8D036ABQ49220712-FE297F86-8F01-4F3D-A757-96B7E886DAE8Q49798105-6369DF98-07A1-4A5E-ADC5-09319741623BQ52657721-AE7BFA6F-1C28-4D44-9643-317E6F5AF408Q52728659-5E943830-4C91-4737-9BFC-FBCF2FC921DA
P2860
Key signaling pathways in the muscle-invasive bladder carcinoma: Clinical markers for disease modeling and optimized treatment.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Key signaling pathways in the ...... eling and optimized treatment.
@en
type
label
Key signaling pathways in the ...... eling and optimized treatment.
@en
prefLabel
Key signaling pathways in the ...... eling and optimized treatment.
@en
P2093
P2860
P356
P1476
Key signaling pathways in the ...... eling and optimized treatment.
@en
P2093
Alex Kiselyov
Svetlana Bunimovich-Mendrazitsky
Vladimir Startsev
P2860
P304
P356
10.1002/IJC.29918
P577
2015-11-06T00:00:00Z